Knightscope Inc
For the period ended Mar 31, 2024. Filed May 16, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 16, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Condensed Financial Statements (Unaudited)
Notes to Condensed financial statements
(Dollars in thousands, unless otherwise stated)
NOTE 1: The Company and Summary of Significant Accounting Policies
Description of Business
Knightscope, Inc. was incorporated on April 4, 2013 under the laws of the State of Delaware.
Knightscope, Inc. (the “Company”) is an innovator in robotics and artificial intelligence (“AI”) technologies focused on public safety. Our technologies are designed to help our clients protect the people, places, and things where we live, work, study, and visit. Our technologies are made in the USA and allow public safety professionals to more effectively identify, deter, intervene, capture, and prosecute criminals.
To support our mission to make the USA the safest country in the world, we design, develop, manufacture, market, deploy and support Autonomous Security Robots (“ASRs”), the proprietary Knightscope Security Operations Center (“KSOC”) software user interface, Blue Light emergency communication devices (“ECDs”), and the Knightscope Emergency Management System (“KEMS”) software platform.
Basis of Presentation and Liquidity
The unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”), pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and note disclosures have been condensed or omitted pursuant to such rules and regulations. The unaudited condensed financial statements have been prepared on the same basis as the annual financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments, necessary for a fair presentation of the period presented. The results of operations for the three months ended March 31, 2024 are not necessarily indicative of the results to the expected for the year ending December 31, 2024 or for other future periods. These condensed financial statements should be read in conjunction with the Company’s audited financial statements and accompanying notes for the year ended December 31, 2023 included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on April 1, 2024. The Company’s significant accounting policies are described in Note 1 to those audited financial statements.
Since its inception, the Company has incurred significant operating losses and negative cash flows from operations which is principally the result of scaling the business and significant research and development activities related to the development, continued improvement, and deployment of the Company’s ASRs (hardware and software).
Cash and cash equivalents on hand were $2.5 million as of March 31, 2024, compared to $2.3 million as of December 31, 2023. The Company has historically incurred losses and negative cashflows from operations. As of March 31, 2024, the Company also had an accumulated deficit of approximately $169.1 million and stockholders’ deficit of approximately $26.6 million. The Company is dependent on additional fundraising in order to sustain its ongoing operations. Based on current operating levels, the Company will need to raise additional funds in the next twelve months by selling additional equity or incurring debt. These factors raise substantial doubt about the Company’s ability to continue as a going concern for the twelve months from the date of this report.
Basic and Diluted Net Loss per Share
Net loss per share of common stock is computed using the two-class method required for participating securities based on their participation rights. All series of convertible preferred stock are participating securities as the holders are entitled to participate in common stock dividends with common stock on an as converted basis. The holders of the Company’s preferred stock are also entitled to noncumulative dividends prior and in preference, to the Company’s common stock and do not have a contractual obligation to share in the losses of the Company. In accordance with the two-class method, earnings allocated to these participating securities, which include participation rights in undistributed earnings with common stock, are subtracted from net loss to determine net loss attributable to common stockholders upon their occurrence.
Basic net loss per share is computed by dividing net loss attributable to common stockholders (net adjusted for preferred stock dividends declared or accumulated) by the weighted average number of common shares outstanding during the period. All participating securities are excluded from basic weighted average shares outstanding. In computing diluted net loss attributable to common stockholders, undistributed earnings are re-allocated to reflect the potential impact of dilutive securities. Diluted net loss per share attributable to common stockholders is computed by dividing net loss attributable to common stockholders by diluted weighted average shares outstanding, including potentially dilutive securities, unless anti-dilutive. Potentially dilutive securities that were excluded from the computation of diluted net loss per share consist of the following:
| | | | | | | |
|---|---|---|---|---|---|---|
| · March 31, · March 31, | ||||||
| · · 2024 · · 2023 | ||||||
| Series A Preferred Stock (convertible to Class B Common Stock) | | | 1,418,381 | | | 1,418,381 |
| Series B Preferred Stock (convertible to Class B Common Stock) | | | 3,498,859 | | | 3,498,859 |
| Series m Preferred Stock (convertible to Class A Common Stock) | | | 1,775,586 | | | 1,808,498 |
| Series m-2 Preferred Stock (convertible to Class B Common Stock) | | | 160,000 | | | 160,000 |
| Series S Preferred Stock (convertible to Class A Common Stock) | | | 2,620,258 | | | 2,693,500 |
| Warrants to purchase Class A Common Stock | | | 1,138,446 | | | 1,138,446 |
| Warrants to purchase Series m-3 Preferred Stock | | | 1,432,786 | | | 1,432,786 |
| Warrants to purchase Series s Preferred Stock | | | 2,941,814 | | | 4,441,814 |
| 2022 Convertible Notes | | | — | | | 5,191,966 |
| Stock options | | | 8,864,302 | | | 9,053,683 |
| Total potentially dilutive shares | | | 23,850,432 | | | 30,837,933 |
As all potentially dilutive securities are anti-dilutive as of March 31, 2024 and 2023, diluted net loss per share is the same as basic net loss per share for each period.
Segments
The Company hasone operating segment andone reportable segment as its chief operating decision maker, who is its Chief Executive Officer, reviews financial information on a regular basis for purposes of allocating resources and evaluating financial performance. All long-lived assets are located in the USA and substantially all revenue is attributed to sellers and buyers based in the USA.
Comprehensive Loss
Net loss was equal to comprehensive loss for the three-month periods ended March 31, 2024 and 2023.
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make judgements, estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses. Specific accounts that require management estimates include, but are not limited to, estimating the useful lives of the Company’s ASRs, property and equipment and intangible assets, certain estimates required within revenue recognition, warranty and allowance for credit losses, determination of deferred tax valuation allowances, estimating fair values of the Company’s share-based awards, warrant liability, and derivative liabilities, inclusive of any contingent assets and liabilities. Actual results could differ from those estimates and such differences may be material to the financial statements.
Reclassifications
Certain reclassifications have been made to the fiscal year 2023 condensed balance sheet to conform to the fiscal year 2024 presentation. The reclassifications had no impact on total assets, total liabilities, or stockholders’ equity.
Accounting Pronouncements Adopted in 2024
None.
Accounting Pronouncements Not Yet Adopted
In November 2023, Financial Accounting Standards Board (“FASB”) released Accounting Standards Update No. 2023-07, Segment Reporting. The amendment improves financial reporting by requiring disclosure of incremental segment information on an annual and interim basis. It is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Management does not believe the implementation of this pronouncement will have a material impact on the Company’s financial statements.
In December 2023, FASB released ASU No. 2023-09,Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The ASU enhances income tax disclosures for the effective tax rate reconciliation and income taxes paid. This ASU is effective for fiscal periods beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating this ASU and the impact it may have on its financial statement disclosures.
Inventory
Inventory, principally purchased components, is stated at the lower of cost or net realizable value. Cost is determined using an average cost, which approximates actual cost on a first-in, first-out basis. Inventory in excess of salable amounts and inventory which is considered obsolete based upon changes in existing technology is written off. At the point of loss recognition, a new lower cost basis
for that inventory is established and subsequent changes in facts and circumstances do not result in the restoration or increase in the new cost basis.
| | | | | | | |
|---|---|---|---|---|---|---|
| · March 31, · · December 31, | ||||||
| · · 2024 · 2023 | ||||||
| Raw materials | | $2,427 | | $2,112 | ||
| Work in process | | | 181 | | | 82 |
| Finished goods | | 275 | | 126 | ||
| | | $2,883 | | $2,320 | ||
In the first quarter of 2024, the Company discontinued the version 3 K5s and wrote off corresponding obsolete inventory of approximately $0.4 million against service cost of revenue, net.
Autonomous Security Robots, net
ASRs consist of materials, ASRs in progress and finished ASRs. ASRs in progress and finished ASRs include materials, labor and other direct and indirect costs used in their production. Finished ASRs are valued using a discrete bill of materials, which includes an allocation of labor and direct overhead based on assembly hours. Depreciation expense on ASRs is recorded using the straight-line method over their estimated expected lives, which currently ranges from 3 to 5 years. Depreciation expense of finished ASRs included in research and development expense amounted to $1 and $2, depreciation expense of finished ASRs included in sales and marketing expense amounted to $0 and $12, and depreciation expense included in cost of revenue, net amounted to $483 and $361 for the three months ended March 31, 2024 and 2023, respectively.
ASRs, net, consisted of the following:
| | | | | | | |
|---|---|---|---|---|---|---|
| · March 31, · December 31, | ||||||
| · · 2024 · · 2023 | ||||||
| Raw materials | | $2,552 | | $3,841 | ||
| ASRs in progress | | | 2,349 | | | 1,575 |
| Finished ASRs | | | 9,597 | | | 12,130 |
| | | | 14,498 | | | 17,546 |
| Accumulated depreciation on Finished ASRs | | | (6,011) | | | (8,701) |
| | | | | | | |
| ASRs, net | | $8,487 | | $8,845 | ||
In the first quarter of 2024, the Company discontinued the version 3 K5s and wrote off approximately $0.4 million against service cost
of revenue, net.
The components of the Finished ASRs, net are as follows:
| | | | | | | |
|---|---|---|---|---|---|---|
| · · March 31, · · December 31, | ||||||
| · · 2024 · · 2023 | ||||||
| ASRs on lease or available for lease | $8,494 | $10,804 | ||||
| Demonstration ASRs | | | 470 | | | 607 |
| Research and development ASRs | | | 67 | | | 194 |
| Charge boxes | | | 566 | | | 525 |
| | | | 9,597 | | | 12,130 |
| Less: accumulated depreciation | | | (6,011) | | | (8,701) |
| Finished ASRs, net | | $3,586 | | $3,429 | ||
Intangible Assets
The gross carrying amounts and accumulated amortization of the intangible assets with determinable lives are as follows:
| · · · · · · · · · · · | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| · · March 31, 2024 | |||||||||
| | | Amortization | | Gross | | | | | |
| · · Period · · carrying · · Accumulated · · Carrying | |||||||||
| Intangible assets with determinable lives · (years) · amount · amortization · amount, net | |||||||||
| Developed technology | | 5 | | $990 | | $(289) | | $701 | |
| Customer relationships | | 8 | | | 950 | | (173) | | 777 |
| Trademark | | 1 | | | 230 | | (230) | | — |
| Total | | | | $2,170 | | $(692) | | $1,478 | |
| · · · · · · · · · · · | ||||||||
|---|---|---|---|---|---|---|---|---|
| · · December 31, 2023 | ||||||||
| · · Amortization · · Gross · · · · · · | ||||||||
| | | Period | | carrying | | Accumulated | | Carrying |
| Intangible assets with determinable lives · · (years) · · amount · amortization · amount, net | ||||||||
| Developed technology | 5 | | $990 | | $(239) | | $751 | |
| Customer relationships | 8 | | 950 | | (144) | | 806 | |
| Trademark | 1 | | 230 | | (230) | | — | |
| Total | | | | $2,170 | | $(613) | | $1,557 |
Intangible assets amortization expense totaled $79 and $137 for the three months ended March 31, 2024 and 2023 respectively. Intangible asset amortization was recorded in sales and marketing and cost of revenue, net - service in the amounts of $30 and $49, respectively for the three month period ended March 31, 2024 compared to amortization expense recorded in sales and marketing and cost of revenue, net - service in the amounts of $87 and $50, respectively for the three month period ended March 31, 2023.
As of March 31, 2024, future intangible assets amortization expense for each of the next five years and thereafter is as follows:
| | | | |
|---|---|---|---|
| Year ending December 31, · Amount | |||
| 2024 (remaining) | | $238 | |
| 2025 | | | 317 |
| 2026 | | | 317 |
| 2027 | | | 275 |
| 2028 | | | 118 |
| Thereafter | | | 213 |
| Total | | $1,478 | |
Other Current Liabilities
Other current liabilities consisted of the following:
| | | | | | | |
|---|---|---|---|---|---|---|
| · March 31, · December 31, | ||||||
| · · 2024 · · 2023 | ||||||
| Sales tax | | $387 | | $364 | ||
| Customer deposits | | 297 | | 239 | ||
| Warranty liability | | 341 | | 406 | ||
| Other | | | 332 | | | 450 |
| | | $1,357 | | $1,459 | ||
Accrued Warranty
The liability for estimated warranty claims is accrued at the time of sale and the expense is recorded in the condensed statements of operations in cost of revenue, net - product. The liability is established using historical warranty claim experience. The current provision may be adjusted to take into account unusual or non-recurring events in the past or anticipated changes in future warranty claims.
Adjustments to the warranty accrual are recorded if actual claim experience indicates that adjustments are necessary. Warranty reserves are reviewed to ensure critical assumptions are updated for known events that may impact the potential warranty liability.
Change in the warranty liability for the three months ended consisted of the following:
| | | | | | | |
|---|---|---|---|---|---|---|
| | March 31, | |||||
| · 2024 · 2023 | ||||||
| Balance January 1, | | $406 | | $145 | ||
| Provision for warranties issued during the quarter | | 41 | | — | ||
| Warranty services provided | | | (106) | | | (36) |
| | | $341 | | $109 | ||
Accrued Expenses
Accrued expenses consisted of the following:
| | | | | | | |
|---|---|---|---|---|---|---|
| · March 31, · December 31, | ||||||
| · · 2024 · · 2023 | ||||||
| Legal, consulting, and financial services | | $382 | | $117 | ||
| Payroll and payroll taxes | | 314 | | 604 | ||
| Credit cards | | 267 | | 244 | ||
| Accrued interest | | | 60 | | | 10 |
| Other | | | 209 | | | 180 |
| | | $1,232 | | $1,155 | ||
Convertible Preferred Warrant Liabilities and Common Stock Warrants
Freestanding warrants to purchase shares of the Company’s preferred stock are classified as liabilities on the balance sheets at their estimated fair value because the underlying shares of preferred stock are contingently redeemable and, therefore, may obligate the Company to transfer assets at some point in the future. The preferred stock warrants are recorded at fair value upon issuance and are subject to remeasurement to their respective estimated fair values. At the end of each reporting period, changes in the estimated fair value of the preferred stock warrants are recorded in the condensed statements of operations. The Company will continue to adjust the liability associated with the preferred stock warrants for changes in the estimated fair value until the earlier of the exercise or expiration of the preferred stock warrants or the completion of a sale of the Company. Upon an initial public offering, the preferred stock warrants will convert into warrants to purchase common stock and any liabilities recorded for the preferred stock warrants will be reclassified to additional paid-in capital and will no longer be subject to remeasurement.
Common stock warrants that are not considered derivative liabilities are accounted for at fair value at the date of issuance in additional paid-in capital. The fair value of these common stock warrants is determined using the Black-Scholes option-pricing model.
Stock-Based Compensation
The Company accounts for stock-based compensation in accordance with Accounting Standards Codification (“ASC”) 718,Compensation - Stock Compensation, which requires that the estimated fair value on the date of grant be determined using the Black-Scholes option pricing model with the fair value recognized over the requisite service period of the awards, which is generally the option vesting period. The Company’s determination of the fair value of the stock-based awards on the date of grant, using the Black-Scholes option pricing model, is affected by the fair value of the Company’s common stock as well as other assumptions regarding a number of highly complex and subjective variables. These variables include but are not limited to the Company’s expected stock price volatility over the term of the awards, and actual and projected employee option exercise behaviors. Because there is insufficient historical information available to estimate the expected term of the stock-based awards, the Company adopted the simplified method of estimating the expected term of options granted by taking the average of the vesting term and the contractual term of the option. The Company recognizes forfeitures as they occur when calculating stock-based compensation for its equity awards.
NOTE 2: Revenue and Deferred Revenue
Revenue Recognition
ASR related revenues
The Company derives its revenues from lease of proprietary ASRs along with access to the browser-based interface KSOC through contracts under the lease accounting that typically have a twelve (12) - month term. In addition, the Company derives non-lease revenue items such as professional services related to ASRs’ deployments, special decals, shipping costs and training if any, recognized when control of these services is transferred to the clients, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services.
ECD related revenues
The Company also derives revenues from sales of its ECDs and related services, such as installation, maintenance, and upgrades. Revenue is recognized when clients sign full or partial certificate of completion, at which point, Knightscope can generate an invoice for its products and services. Clients also have the option to sign up for ongoing preventative and maintenance agreements. The maintenance revenue is recognized in the period the service is performed and the Company has determined that term of the contracts has been fulfilled. Installation or upgrades revenue are recognized upon completion of the project/contracts. In certain cases, deferred revenue is recognized to account for unfinished contracts.
The Company determines revenue recognition through the following steps:
| ● | identification of the contract, or contracts, with a client; |
| ● | identification of the performance obligations in the contract; |
| ● | determination of the transaction price; |
| ● | allocation of the transaction price to the performance obligations in the contract; and |
| ● | recognition of revenue when, or as, the Company satisfies a performance obligation. |
The Company recognizes ASR subscription revenue as follows:
ASR subscription revenue is generated from lease of proprietary ASRs along with access to the browser-based interface KSOC through contracts that typically have 12 - month terms. These revenue arrangements adhere to lease accounting guidance and are classified as leases for revenue recognition purposes. Currently, all revenue arrangements qualify as operating leases where consideration allocated to the lease deliverables is recognized ratably over the lease term.
Deferred revenue
In connection with the Company’s Machine-as-a-Service (“MaaS”) subscription for the Company’s ASRs, the Company’s standard billing terms are annual in advance. In these situations, the Company records the invoices as deferred revenue and amortizes the subscription amount when the services are delivered, which generally is a 12-month period. In addition, the Company refers certain transactions to Dimension and Balboa Capital, whereby Dimension or Balboa Capital advances the full value of the MaaS subscription to the Company, less a processing fee. The advanced payment is recorded in deferred revenue and amortized over the term of the subscription once the ASR is delivered to the deployment site.
The Company derives its revenue from the lease subscription of its proprietary ASRs along with access to its browser and mobile based software interface, KSOC. MaaS subscription agreements typically have a twelve (12)-month term.
The Company also records deferred revenue from unfinished contracts for certain ECD related services.
Deferred revenue includes billings in excess of revenue recognized. Revenue recognized at a point in time generally does not result in significant increases in deferred revenue. Revenue recognized over a period generally results in a majority of the increases in deferred revenue as the performance obligations are fulfilled after the billing event. Deferred revenue was as follows:
| · · · | ||
|---|---|---|
| | March 31, 2024 | |
| Deferred revenue - short term | | $1,659 |
| Revenue recognized in the three months ended related to amounts included in deferred revenue as of January 1, 2024 | | $715 |
Deferred revenue represents amounts invoiced to customers for contracts for which revenue has yet to be recognized based for subscription services to be delivered to the Company’s clients. Typically, the timing of invoicing is based on the terms of the contract.
Customer Deposits
Customer deposits primarily relate to sales of ECDs to certain customers dependent upon credit worthiness. The customer deposits are recorded as current liabilities and reclassed to a contra accounts receivable account at the time that the final invoice for the sale is generated following the completion of the revenue recognition criteria.
Disaggregation of revenue
The Company disaggregates revenue from contracts with customers into the timing of the transfers of goods and services by product line.
The following table summarizes revenue by product line and timing of recognition:
| | | | | | | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · Three Months Ended March 31, | ||||||||||||||||||
| · · 2024 · · 2023 | ||||||||||||||||||
| · Point in time · Over time · Total · Point in time · Over time · Total | ||||||||||||||||||
| ASRs | | $25 | | $965 | | $990 | | $20 | | $1,002 | | $1,022 | ||||||
| ECDs | | | 1,226 | | | 38 | | | 1,264 | | | 1,787 | | | 88 | | | 1,875 |
| Total | | $1,251 | | $1,003 | | $2,254 | | $1,807 | | $1,090 | | $2,897 | ||||||
Other revenue, net
Other non-ASR service-related revenues such as deployment services, decals and training revenue are recognized when services are delivered. Revenue from these transactions has been immaterial for all periods presented and is included in service revenue, net.
NOTE 3: Fair Value Measurement
The Company determines the fair market values of its financial instruments based on the fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The following are three levels of inputs that may be used to measure fair value:
| ● | Level 1 – Quoted prices in active markets for identical assets or liabilities. The Company considers a market to be active when transactions for the asset occur with sufficient frequency and volume to provide pricing information on an ongoing basis. |
| ● | Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. |
| ● | Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The valuation of Level 3 investments requires the use of significant management judgments or estimation. |
In certain cases where there is limited activity or less transparency around inputs to valuation, securities are classified as Level 3. Level 3 liabilities that are measured at fair value on a recurring basis consist of the convertible preferred stock warrant liabilities. The inputs used in estimating the fair value of the warrant liabilities are described in Note 6 --Capital Stock and Warrants.
The following tables summarize, for each category of assets or liabilities carried at fair value, the respective fair value as of March 31, 2024 and December 31, 2023, and the classification by level of input within the fair value hierarchy:
| | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · Total · Level 1 · Level 2 · Level 3 | ||||||||||||
| March 31, 2024 | | | | | ||||||||
| Assets | | | | | | | | | | | | |
| Cash equivalents: | | | | | | | | | | | | |
| Money market funds | | $1,107 | | $1,107 | | $— | | $— | ||||
| Liabilities | | | | | | | | | | | | |
| Warrant liability – Series m-3 Preferred Stock | | $212 | | $— | | $— | | $212 | ||||
| Warrant liability – Series S Preferred Stock | | $5,086 | | $— | | $— | | $5,086 | ||||
| Derivative liability – Class A Common Stock warrants | | $179 | | $— | | $— | | $179 | ||||
| | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · Total · Level 1 · Level 2 · Level 3 | ||||||||||||
| December 31, 2023 | | | | | ||||||||
| Assets | | | | | | | | | | | | |
| Cash equivalents: | | | | | | | | | | | | |
| Money market funds | | $1,104 | | $1,104 | | $— | | $— | ||||
| Liabilities | | | | | | | | | | | | |
| Warrant liability – Series m-3 Preferred Stock | | $284 | | $— | | $— | | $284 | ||||
| Warrant liability – Series s Preferred Stock | | $5,692 | | $— | | $— | | $5,692 | ||||
| Derivative liability – Class A Common Stock warrants | | $271 | | $— | | $— | | $271 | ||||
During the three-month periods ended March 31, 2024 and 2023, there wereno transfers between Level 1, Level 2, or Level 3 assets or liabilities reported at fair value on a recurring basis and the valuation techniques used did not change compared to the Company’s established practice.
The following table sets forth a summary of the changes in the fair value of Company’s Level 3 warrant and derivative liabilities during the three-month periods ended March 31, 2024 and 2023, which were measured at fair value on a recurring basis:
| | | | | | | |
|---|---|---|---|---|---|---|
| · · March 31, · · March 31, | ||||||
| · 2024 · 2023 | ||||||
| Beginning Balance | | $6,247 | | $11,157 | ||
| Revaluation of Series m-3, S Preferred Stock warrants and derivative liability | | | (770) | | | (4,622) |
| Ending Balance | | $5,477 | | $6,535 | ||
The following table sets forth a summary of the changes in the fair value of Company’s Level 3 convertible note liabilities during the three-month periods ended March 31, 2024 and 2023, which were measured at fair value on a recurring basis:
| · · · · · · | ||||
|---|---|---|---|---|
| · March 31, · March 31, | ||||
| | | 2024 | | 2023 |
| Beginning Balance | | $— | | $8,152 |
| Notes converted | | — | | (4,174) |
| Interest accretion | | — | | 497 |
| Revaluation of 2022 Convertible Notes | | — | | (43) |
| Ending Balance | | $— | | $4,432 |
NOTE 4: Debt Obligations
The amortized carrying amount of the Company’s debt obligations consists of the following:
| | | | | | | |
|---|---|---|---|---|---|---|
| · · March 31, · · December 31, | ||||||
| · 2024 · 2023 | ||||||
| Bonds, net of unamortized issuance costs of $375 and $194, respectively | | $3,898 | | $1,242 | ||
| Less: current portion of debt obligations | | | — | | | — |
| Non-current portion of debt obligations | | $3,898 | | $1,242 | ||
The Company issued Public Safety Infrastructure Bonds with a total principal amount of approximately $2.8 million, in aggregate, generating net proceeds to the Company of approximately $2.6 million, net of issuance costs of approximately $0.2 million during the three months ended March 31, 2024.
NOTE 5: Stock-Based Compensation
Equity Incentive Plans
In April 2014, the Board of Directors adopted the 2014 Equity Incentive Plan (the “2014 Plan”) allowing for the issuance of up to 2,000,000 shares of common stock through grants of options, stock appreciation rights, restricted stock or restricted stock units. In December 2016, the 2014 Plan was terminated, and the Company’s Board of Directors adopted a new equity incentive plan defined as the 2016 Equity Incentive Plan (the “2016 Plan”) in which the remaining 1,936,014 shares available for issuance under the 2014 Plan at that time were transferred to the Company’s 2016 Plan. Awards outstanding under the 2014 Plan at the time of the 2014 Plan’s termination will continue to be governed by their existing terms. The shares underlying any awards that are forfeited, canceled, repurchased or are otherwise terminated by the Company under the 2014 Plan will be added back to the shares of common stock available for issuance under the Company’s 2016 Plan. The 2016 Plan provides for the granting of stock awards such as incentive stock options, non - statutory stock options, stock appreciation rights, restricted stock or restricted stock units to employees, directors and outside consultants as determined by the Board of Directors.
On June 23, 2022, following approval by the Board of Directors, the Company’s stockholders adopted the 2022 Equity Incentive Plan (the “2022 Plan”) allowing for the issuance of up to 5,000,000 shares of Class A Common Stock through grants of options, stock appreciation rights, restricted stock awards, restricted stock units, performance awards, and other stock or cash-based awards. In connection with the adoption of the 2022 Plan, shares previously available for issuance under the 2016 Plan became available for issuance under the 2022 Plan. The number of shares authorized under the 2022 Plan will be increased each January 1 st, beginning January 1, 2023 and ending on (and including) January 1, 2032, by an amount equal to the lesser of (a)5% of our Class A Common Stock and Class B Common Stock outstanding on December 31st of the immediately preceding calendar year (rounded up to the nearest whole share) and (b) a number of shares determined by the plan administrator. Shares subject to awards (including under the 2016 Plan and the 2014 Plan) that lapse, expire, terminate, or are canceled prior to the issuance of the underlying shares or that are subsequently forfeited to or otherwise reacquired by us will be added back to the shares of common stock available for issuance under the 2022 Plan.
The Board of Directors may grant stock options under the 2022 Plan at an exercise price of not less than 100% of the fair market value of the Company’s common stock on the date the option is granted. Options generally have a term often years from the date of grant. Incentive stock options granted to employees who, on the date of grant, own stock representing more than 10% of the voting power of all of the Company’s classes of stock, are granted at an exercise price of not less than 110% of the fair market value of the Company’s common stock. The maximum term of incentive stock options granted to employees who, on the date of grant, own stock having more than 10% of the voting power of all of the Company’s classes of stock, may not exceed five years. The Board of Directors also determines the terms and conditions of awards, including the vesting schedule and any forfeiture provisions. Options granted under the 2022 Plan may vest upon the passage of time, generally four years, or upon the attainment of certain performance criteria established by the Board of Directors. The Company may from time-to-time grant options to purchase common stock to non-employees for advisory and consulting services. At each measurement date, the Company will remeasure the fair value of these stock options using the Black - Scholes option pricing model and recognize the expense ratably over the vesting period of each stock option award. Stock options comprise all of the awards granted since the 2022 Plan’s inception.
Stock option activity under all of the Company’s equity incentive plans for the three-month period ended of March 31, 2024 is as follows:
| | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| | | | | | | | | | Weighted | | | |
| · · · · · · Weighted · · Average · · · | ||||||||||||
| · · Shares · · Number of · · Average · · Remaining · · Aggregate | ||||||||||||
| · · Available for · · Shares · · Exercise · · Contractual · · Intrinsic | ||||||||||||
| · Grant · Outstanding · Price · Life (Years) · Value (000’s) | ||||||||||||
| Available and outstanding as of December 31, 2023 | | 99,363 | | 10,069,394 | | $2.72 | | 7.14 | | $141 | ||
| Granted | | (20,000) | | 20,000 | | | 0.64 | | | | | |
| Exercised | | — | | — | | | | | | | | |
| Forfeited | | 1,225,092 | | (1,225,092) | | | 4.96 | | | | | |
| Available and outstanding as of March 31, 2024 | | 1,304,455 | | 8,864,302 | | $2.40 | | 7.07 | | $80 | ||
| Vested and exercisable as of March 31, 2024 | | | | 6,446,174 | | $2.20 | | 6.49 | | $75 | ||
The weighted average grant date fair value of options granted during the three months ended March 31, 2024 was $0.36 per share. There wereno options exercised during the three month period ended March 31, 2024 compared to 213,020 options exercised in the prior year period. The fair value of the options that vested during the three months ended March 31, 2024 and 2023 was $345 and $793, respectively.
As of March 31, 2024, the Company had unamortized stock-based compensation expense of $2.3 million that will be recognized over the weighted average remaining vesting term of options of 2.52 years.
The assumptions utilized for option grants during the three-month periods ended March 31, 2024 and 2023 are as follows:
| | | | | | |
|---|---|---|---|---|---|
| | Three months ended | ||||
| · · March 31, · | |||||
| · · 2024 · 2023 · | |||||
| Risk-free interest rate | | 4.49% | 3.76% | ||
| Expected dividend yield | | —% | —% | ||
| Expected volatility | | 54.89% | 54.09% | ||
| Expected term (in years) | | 6.02 | | 5.99 | |
A summary of stock-based compensation expense recognized in the Company’s condensed statements of operations is as follows:
| | | | | | | |
|---|---|---|---|---|---|---|
| | Three months ended | |||||
| · · March 31, | ||||||
| · · 2024 · 2023 | ||||||
| Cost of services | | $57 | | $93 | ||
| Research and development | | | 122 | | | — |
| Sales and marketing | | | 48 | | | 53 |
| General and administrative | | | 107 | | | 300 |
| Total | | $334 | | $446 | ||
NOTE 6: Capital Stock and Warrants
The following tables summarize convertible preferred stock authorized and issued and outstanding as of March 31, 2024:
| | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|
| · · Shares · Proceeds Net · Aggregate | ||||||||||
| · · Shares · · Issued and · · of Issuance · · Liquidation | ||||||||||
| · · Authorized · · Outstanding · · Costs · · Preference | ||||||||||
| Series A Preferred Stock | | 8,936,015 | | 1,418,381 | | $614 | | $1,267 | ||
| Series B Preferred Stock | | 4,707,501 | | 3,498,859 | | | 7,098 | | | 7,138 |
| Series m Preferred Stock | | 6,666,666 | | 1,775,586 | | | 4,611 | | | 5,327 |
| Series m - 1 Preferred Stock | | 333,334 | | — | | | — | | | — |
| Series m-2 Preferred Stock | | 1,660,756 | | 160,000 | | | 480 | | | 480 |
| Series m-3 Preferred Stock | | 3,490,658 | | — | | | — | | | — |
| Series m-4 Preferred Stock | | 4,502,061 | | — | | | — | | | — |
| Series S Preferred Stock | | 13,108,333 | | 2,620,258 | | | 21,212 | | | 20,962 |
| Total Preferred Stock | | 43,405,324 | | 9,473,084 | | $34,015 | | $35,174 | ||
A summary of the Company’s outstanding warrants as of March 31, 2024 is as follows:
| · · · · · · · | ||||||
|---|---|---|---|---|---|---|
| Class of shares · Number of Warrants · · Exercise Price · Expiration Date | ||||||
| Series m-3 Preferred Stock | | 1,432,786 | | $4.0000 | | December 31, 2027 |
| Series S Preferred Stock | | 2,941,814 | | $4.5000 | | December 31, 2027 |
| Class A Common Stock | | 1,138,446 | | $3.2500 | | October 13, 2027 |
Common Stock Reserved for Future Issuance
Shares of common stock reserved for future issuance relate to outstanding preferred stock, warrants and stock options as follows:
| | | |
|---|---|---|
| · March 31, | ||
| | | 2024 |
| Series A Preferred Stock | | 1,418,381 |
| Series B Preferred Stock | | 3,498,859 |
| Series m Preferred Stock | | 1,775,586 |
| Series m-2 Preferred Stock | | 160,000 |
| Series S Preferred Stock | | 2,620,258 |
| Stock options to purchase common stock | | 8,864,302 |
| Warrants outstanding for future issuance of convertible preferred stock and common stock | | 5,513,046 |
| Stock options available for future issuance | | 1,304,455 |
| Total shares of Class A Common Stock reserved | | 25,154,887 |
At-the-Market Offering Program
In February 2023, the Company commenced an at-the-market offering program with H.C. Wainwright & Co., LLC (“Wainwright”), as sales agent, in connection with which the Company filed a prospectus supplement filed on February 9, 2023 (the “February Prospectus Supplement”), allowing the Company to offer and sell from time to time up to $20.0 million in shares of Class A Common Stock, subject to, and in accordance with, SEC rules. Pursuant to General Instruction I.B.6 of Form S-3, the February Prospectus Supplement provided that in no event would the Company sell any securities in a public primary offering with a value exceeding one-third of the Company’s non-affiliated public float in any 12-month period unless the Company’s non-affiliated public float subsequently rose to $75.0 million or more. On August 18, 2023, after the Company’s non-affiliated public float subsequently rose to an amount greater than $75.0 million, the Company filed a new prospectus supplement (the “August Prospectus Supplement”) providing for the offer and sale from time to time of up to $25.0 million in shares of Class A Common Stock subject to, and in accordance with, SEC rules. During the three months ended March 31, 2024, the Company issued 13,512,738 shares of Class A Common Stock under the at-the-market offering program for net proceeds of approximately $7.1 million, net of brokerage and placement fees of approximately $0.3 million.
NOTE 7: Related parties and related-party transactions
One of the Company’s vendors, Konica Minolta, Inc. (“Konica Minolta”), is a stockholder of the Company. Konica Minolta provides the Company with repair services to its ASRs. The Company paid Konica Minolta $60 and $99 in service fees for three-month periods ended March 31, 2024 and 2023, respectively. The Company had payables of $80 and $84 owed to Konica Minolta as of March 31, 2024 and December 31, 2023, respectively.
NOTE 8: Commitments and contingencies
Leases
The Company leases facilities for office space under non-cancelable operating lease agreements. The Company leases space for its corporate headquarters in Mountain View, California through August 2025.
As of March 31, 2024 and December 31, 2023, the components of leases and lease costs are as follows:
| | | | | | | |
|---|---|---|---|---|---|---|
| | March 31, 2024 | December 31, 2023 | ||||
| Operating leases | | | | | | |
| Operating lease right-of-use assets | | $1,273 | | $1,458 | ||
| | | | | | | |
| Operating lease liabilities, current portion | | $755 | | $733 | ||
| Operating lease liabilities, non-current portion | | | 512 | | | 711 |
| Total operating lease liabilities | | $1,267 | | $1,444 | ||
Operating lease costs were approximately $0.3 million and $0.2 million for the three-month periods ended March 31, 2024 and 2023, respectively.
As of March 31, 2024, future minimum operating lease payments for each of the next three years and thereafter is as follows:
| | | | |
|---|---|---|---|
| Years ending December 31, · Amount | |||
| 2024 (remaining) | | $640 | |
| 2025 | | | 675 |
| 2026 | | | 73 |
| Total future minimum lease payments | | | 1,388 |
| Less - Interest | | | (121) |
| Present value of lease liabilities | | $1,267 | |
Weighted average remaining lease term is 1.7 years as of March 31, 2024 and the weighted average discount rate is 11.6%.
Legal Matters
The Company may be subject to pending legal proceedings and regulatory actions in the ordinary course of business; however, no such claims have been identified as of March 31, 2024 that would have a material adverse effect on the Company’s financial position, results of operations or cash flows.
The Company from time to time enters into contracts that contingently require the Company to indemnify parties against third party claims. These contracts primarily relate to: (i) arrangements with clients which generally include certain provisions for indemnifying clients against liabilities if the services infringe a third party’s intellectual property rights, (ii) the Regulation A Issuer Agreement where the Company may be required to indemnify the placement agent for any loss, damage, expense or liability incurred by the other party in any claim arising out of a material breach (or alleged breach) as a result of any potential violation of any law or regulation, or any third party claim arising out of any investment or potential investment in the offering, and (iii) agreements with the Company’s officers and directors, under which the Company may be required to indemnify such persons from certain liabilities arising out of such persons’ relationships with the Company. The Company has not incurred any material costs as a result of such obligations and has not accrued any liabilities related to such obligations in the condensed financial statements as of March 31, 2024 and December 31, 2023.
Sales Tax Contingencies
The Company has historically not collected state sales tax on the sale of its MaaS product offering but has paid sales tax and use tax on all purchases of raw materials and in conjunction with the financing arrangement of the Company’s ASRs with Farnam Street Financial. The Company’s MaaS product offering may be subject to sales tax in certain jurisdictions. If a taxing authority were to successfully assert that the Company has not properly collected sales or other transaction taxes, or if sales or other transaction tax laws or the interpretation thereof were to change, and the Company was unable to enforce the terms of their contracts with Clients that give the right to reimbursement for the assessed sales taxes, tax liabilities in amounts that could be material may be incurred. Based on the Company’s assessment, the Company has recorded a use tax liability of $0.4 million as of March 31, 2024 and December 31, 2023 which has been included in other current liabilities on the accompanying condensed balance sheets. The Company continues to analyze possible sales tax exposure but does not currently believe that any individual claim or aggregate claims that might arise will ultimately have a material effect on its results of operations, financial position or cash flows.
NOTE 9: Subsequent Events
Pursuant to the Sales Agreement with Wainwright relating to the sale of shares of the Company’s Class A Common Stock, the Company filed a prospectus supplement with the SEC on April 8, 2024 pursuant to Rule 424(b)(5) (the “April Prospectus Supplement”). In accordance with the terms of the Sales Agreement and the April Prospectus Supplement, the Company may offer and sell shares of its Class A Common Stock having an aggregate offering price of up to $6.4 million from time to time through or to Wainwright acting as its agent or principal. As of April 4, 2024, the aggregate market value of the Company’s outstanding Class A Common Stock held by non-affiliates (“public float”) was approximately $54.9 million. During the prior 12 calendar month period that ended on and included the date of the April Prospectus Supplement, the Company had offered and sold 20,969,876 shares of Class A Common Stock for approximately $11.9 million pursuant to General Instruction I.B.6 of Form S-3. Pursuant to General Instruction I.B.6 of Form S-3, in no event will the Company sell securities registered on the registration statement, of which the prospectus is a part, in a public primary offering with a value exceeding more than one-third of the Company’s public float in any 12-month period so long as the Company’s public float remains below $75.0 million.
From April 1, 2024 to May 10, 2024, the Company sold 4,132,855 shares of Class A Common Stock, generating approximately $1.8 million of proceeds, net of commissions and other issuance costs, under the Company’s at-the-market offering program.
On April 5, 2024, the Company held a special meeting of stockholders (the “Special Meeting”) at which the Company’s stockholders approved an amendment (the “Amendment”) to the Company’s Amended and Restated Certificate of Incorporation to increase the number of authorized shares of the Company’s Class A Common Stock from 114,000,000 to 228,000,000 shares, as described in the Company’s Definitive Proxy Statement on Schedule 14A filed with the SEC on February 23, 2024 (the “Proxy Statement”). The Board of Directors had previously approved the Amendment and, on April 5, 2024, the Company filed a Certificate of Amendment to the Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware to effect the Amendment, which became effective upon filing with the Secretary of State.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.